John T. Williams

Oregon Health and Science University, Portland, OR 
"John Williams"
Mean distance: 12.75 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lebowitz JJ, Banerjee A, Qiao C, et al. (2022) Synaptotagmin-1 is a Ca sensor for somatodendritic dopamine release. Cell Reports. 42: 111915
Rodriguez-Contreras D, Gong S, Lebowitz JJ, et al. (2022) Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation . Molecular Pharmacology
Condon AF, Asad N, Dore TM, et al. (2022) Co-activation of GPCRs facilitate GIRK-dependent current. The Journal of Physiology
Adhikary S, Williams JT. (2022) Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System. Frontiers in Systems Neuroscience. 16: 937126
Adhikary S, Koita O, Lebowitz JJ, et al. (2022) Agonist specific regulation of G protein-coupled receptors after chronic opioid treatment. Molecular Pharmacology
Lebowitz JJ, Trinkle M, Bunzow JR, et al. (2021) Subcellular localization of D2 receptors in the murine substantia nigra. Brain Structure & Function
Condon AF, Robinson BG, Asad N, et al. (2021) The residence of synaptically released dopamine on D2 autoreceptors. Cell Reports. 36: 109465
Rodriguez-Contreras D, Condon AF, Buck DC, et al. (2021) Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant. Acs Chemical Neuroscience
van der Weijden MCM, Rodriguez-Contreras D, Delnooz CCS, et al. (2020) A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype. Movement Disorders : Official Journal of the Movement Disorder Society
James A, Williams J. (2020) Basic Opioid Pharmacology - An Update. British Journal of Pain. 14: 115-121
See more...